Your browser of choice has not been tested for use with If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More

Biotechnology Stocks

A list of publicly traded biotechnology and biotech-related stocks and ETFs.
Sun, May 19th, 2024

Biotechnology (biotech) Stocks are publicly traded companies that develop pharmaceutical drugs used in the treatment of disease. You can use Barchart's Biotech Stocks list to find investment opportunities and compare stocks involved in this hot industry.

View Profiles of these companies.

Biotechnology Stocks News

AstraZeneca pulls its COVID-19 vaccine from the European market

The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled

$SPX : 5,303.27 (+0.12%)
$DOWI : 40,003.59 (+0.34%)
$IUXX : 18,546.23 (-0.06%)
AZN.LN : 12,110.002 (-0.46%)
AZN : 76.90 (-0.18%)
Vertex Pharma scientist talks about the long road to developing non-addictive painkillers

Patients suffering from pain have limited options when it comes to medication

On eve of Japanese prime minister's visit to North Carolina, Fujifilm announces more jobs there

A subsidiary of Japanese-based Fujifilm Corp. plans to expand further a massive biopharmaceutical manufacturing plant in the state, even as the initial phase is not yet complete

TM : 219.76 (+1.92%)
FUJIY : 10.9250 (+0.32%)
US rivalry with China expands to biotech. Lawmakers see a failure to compete and want to act

U.S. lawmakers are raising alarms about what they see as America’s failure to compete with China in biotechnology

$SPX : 5,303.27 (+0.12%)
$DOWI : 40,003.59 (+0.34%)
$IUXX : 18,546.23 (-0.06%)
As investors pile into psychedelics, idealism gives way to pharma economics

Dozens of psychedelic startup companies are racing to begin selling mind-expanding drugs for depression and other mental health conditions, riding a wave of promising research and media hype

PYPL : 64.48 (+0.59%)
Consulting firm McKinsey agrees to $78 million settlement with insurers over opioids

Consulting firm McKinsey and Co. has agreed to pay $78 million to settle claims from insurers and health care funds that its marketing work with Purdue Pharma helped fuel an opioid addiction crisis

$SPX : 5,303.27 (+0.12%)
$DOWI : 40,003.59 (+0.34%)
$IUXX : 18,546.23 (-0.06%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar